The company operates through three segments: Healthcare, Education, and Commercial. Adjusted EBITDA rose 18.1% to $237.5 million and adjusted diluted EPS increased 21.0% to $7.83 in 2025. Huron is positioned as a market leader in regulated industries with strong organic growth and strategic M&A execution.
Cyborg Score Rationale
Huron demonstrates strong fundamentals with 12% organic revenue growth, 21% EPS growth, expanding margins (18.1% EBITDA growth), and record profitability. Strategic M&A activity and diverse end-market exposure reduce cyclical risk. Recent board authorization of increased share repurchase reflects confidence.
Top Insights
Record 2025 revenue of $1.66B with 12% organic growth and five consecutive years of growth trajectory